SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-000956
Filing Date
2019-01-25
Accepted
2019-01-25 16:01:43
Documents
7
Period of Report
2019-01-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 46255
2 ex1-1.htm EX-1.1 321522
3 ex5-1.htm EX-5.1 13286
4 ex99-1.htm EX-99.1 17350
5 ex99-1_001.jpg GRAPHIC 53194
6 ex99-2.htm EX-99.2 16943
7 ex99-2_001.jpg GRAPHIC 56410
  Complete submission text file 0001493152-19-000956.txt   567824
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 19542565
SIC: 2834 Pharmaceutical Preparations